Praxis Precision Medicines Ownership | Who Owns Praxis Precision Medicines?


OverviewForecastRevenueFinancialsChartTranscripts

Praxis Precision Medicines Ownership Summary


Praxis Precision Medicines is owned by 114.04% institutional investors, 0.18% insiders. Adage capital partners gp is the largest institutional shareholder, holding 11.06% of PRAX shares. American Funds SMALLCAP World A is the top mutual fund, with 3.71% of its assets in Praxis Precision Medicines shares.

PRAX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPraxis Precision Medicines114.04%0.18%-14.22%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Adage capital partners gp2.37M11.06%$125.83M
Blackrock funding, inc. /de1.80M8.39%$95.46M
Perceptive advisors1.56M7.29%$82.92M
Point72 asset management1.50M6.97%$79.29M
Vanguard group1.27M5.90%$67.17M
Janus henderson group929.52K4.92%$71.62M
Price t rowe associates inc /md/1.00M4.67%$53.19M
Cormorant asset management, lp1.00M4.66%$53.00M
State street907.11K4.22%$48.08M
Soleus capital management859.17K4.00%$45.54M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Velan capital investment management lp132.81K6.61%$7.04M
72 investment65.93K5.14%$3.49M
Cormorant asset management, lp1.00M3.66%$53.00M
5am venture management170.00K3.30%$9.01M
Exome asset management102.00K3.27%$5.41M
Acuta capital partners49.75K2.72%$2.64M
Perceptive advisors1.56M2.39%$82.92M
Soleus capital management859.17K2.29%$45.54M
Lion point capital, lp5.70K1.72%$302.10K
Highvista strategies95.00K1.23%$5.04M

Top Buyers

HolderShares% AssetsChange
Perceptive advisors1.56M2.39%811.63K
Point72 asset management1.50M0.13%541.91K
Janus henderson group929.52K0.04%405.96K
Adage capital partners gp2.37M0.20%399.50K
Woodline partners lp417.67K0.10%371.72K

Top Sellers

HolderShares% AssetsChange
Vr adviser---989.99K
Capital research global investors---853.75K
Ra capital management---761.96K
Cormorant asset management, lp1.00M3.66%-625.00K
Morgan stanley643.50K0.00%-582.84K

New Positions

HolderShares% AssetsChangeValue
Norges bank118.90K0.00%118.90K$9.15M
Readystate asset management lp109.18K0.25%109.18K$5.79M
Marshall wace, llp68.14K0.00%68.14K$3.61M
Qube research57.30K0.00%57.30K$3.04M
Dimensional fund advisors lp37.41K0.00%37.41K$1.98M

Sold Out

HolderChange
Twin peaks wealth advisors-1.00
Ifp advisors-1.00
National bank of canada /fi/-1.00
Parallel advisors-2.00
Creative financial designs inc /adv-6.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20251598.16%24,489,0118.54%1141.03%884.76%4132.26%
Jun 30, 2025155-6.06%24,147,5133.31%1120.91%884.76%33-35.29%
Mar 31, 202516-90.86%7,276,078-66.50%340.26%10-89.47%3-94.12%
Dec 31, 202473-50.00%6,922,762-63.30%360.37%44-41.33%21-54.35%
Sep 30, 202414617.74%18,864,9992.39%991.04%75-8.54%4670.37%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds SMALLCAP World A748.24K3.71%-139.82K
Vanguard Total Stock Mkt Idx Inv673.37K3.20%-14.92K
Vanguard US Total Market Shares ETF541.27K2.68%-
iShares Russell 2000 ETF430.21K2.04%-
Janus Henderson Global Life Sciences402.45K1.98%223.64K
US Small-Cap Growth II Equity Comp393.45K1.93%4.67K
Janus Henderson Global Life Sciences D402.45K1.91%43.33K
Renaissance Global Health Care388.36K1.85%-
Janus Global Life Science AUSD335.21K1.59%190.85K
Janus Henderson Glb Life Scn I2 USD327.75K1.56%-6.59K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 20, 2025Nemiroff Alex General Counsel and SecretarySell$188.79K
Nov 20, 2025Nemiroff Alex General Counsel and SecretarySell$1.77M
Nov 20, 2025Nemiroff Alex General Counsel and SecretarySell$327.14K
Nov 20, 2025Nemiroff Alex General Counsel and SecretarySell$2.57M
Nov 20, 2025Mastrocola Lauren Principal Accounting OfficerSell$2.20M

Insider Transactions Trends


DateBuySell
2025 Q4-16
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q4-2

PRAX Ownership FAQ


Who Owns Praxis Precision Medicines?

Praxis Precision Medicines shareholders are primarily institutional investors at 114.04%, followed by 0.18% insiders and -14.22% retail investors. The average institutional ownership in Praxis Precision Medicines's industry, Biotech Stocks , is 45.22%, which Praxis Precision Medicines exceeds.

Who owns the most shares of Praxis Precision Medicines?

Praxis Precision Medicines’s largest shareholders are Adage capital partners gp (2.37M shares, 11.06%), Blackrock funding, inc. /de (1.8M shares, 8.39%), and Perceptive advisors (1.56M shares, 7.29%). Together, they hold 26.73% of Praxis Precision Medicines’s total shares outstanding.

Does Blackrock own Praxis Precision Medicines?

BlackRock is not among the top 10 institutional shareholders of Praxis Precision Medicines.

Who is Praxis Precision Medicines’s biggest shareholder by percentage of total assets invested?

Velan capital investment management lp is Praxis Precision Medicines’s biggest shareholder by percentage of total assets invested, with 6.61% of its assets in 132.8K Praxis Precision Medicines shares, valued at 7.04M$.

Who is the top mutual fund holder of Praxis Precision Medicines shares?

American Funds SMALLCAP World A is the top mutual fund holder of Praxis Precision Medicines shares, with 3.71% of its total shares outstanding invested in 748.24K Praxis Precision Medicines shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools